Literature DB >> 21477167

Detection of anti-Siglec-14 alloantibodies in blood components implicated in nonhaemolytic transfusion reactions.

Kazuta Yasui, Takashi Angata, Nobuki Matsuyama, Rika A Furuta, Takafumi Kimura, Hitoshi Okazaki, Yoshihiko Tani, Susumu Nakano, Hisashi Narimatsu, Fumiya Hirayama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21477167     DOI： 10.1111/j.1365-2141.2010.08488.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

Review 2.  Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.

Authors:  Takashi Angata; Corwin M Nycholat; Matthew S Macauley
Journal:  Trends Pharmacol Sci       Date:  2015-10       Impact factor: 14.819

3.  Soluble Siglec-14 glycan-recognition protein is generated by alternative splicing and suppresses myeloid inflammatory responses.

Authors:  Po-Chun Jimmy Huang; Penk-Yeir Low; Iren Wang; Shang-Te Danny Hsu; Takashi Angata
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

4.  Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation.

Authors:  Takashi Angata; Takeo Ishii; Takashi Motegi; Ritsuko Oka; Rachel E Taylor; Paula Campos Soto; Yung-Chi Chang; Ismael Secundino; Cong-Xiao Gao; Kazuaki Ohtsubo; Shinobu Kitazume; Victor Nizet; Ajit Varki; Akihiko Gemma; Kozui Kida; Naoyuki Taniguchi
Journal:  Cell Mol Life Sci       Date:  2013-03-22       Impact factor: 9.261

5.  An Elderly Woman with Anti-neutrophil Antibody-positive Agranulocytosis Who Responded to High-dose Intravenous Methylprednisolone.

Authors:  Shiro Koh; Hideo Koh; Yuki Kubo; Maiko Kuroda; Mitsutaka Nishimoto; Takuro Yoshimura; Yasuhiro Nakashima; Takahiko Nakane; Hirohisa Nakamae; Masahiko Ohsawa; Masayuki Hino
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.